FAM215A and myocardial infarction: So far, Raluca Maria Boteanu et al. found that the expression of S100a8 and S100a9 increased after MI, and short-term use of an S100a9 blocker can reduce the expression of apoptosis-related proteins in MI mouse models, which is beneficial to cardiac recovery after MI [50].